Study of Pembrolizumab (MK-3475) Versus Placebo in Combination With Neoadjuvant Chemotherapy & Adjuvant Endocrine Therapy in the Treatment of Early-Stage Estrogen Receptor-Positive, Human Epidermal Growth Factor Receptor 2-Negative (ER+/HER2-) Breast Cancer (MK-3475-756/KEYNOTE-756)

~22 mi. (Nordhausen, Germany, +207 more cities)

MVZ Nordhausen gGmbH - Praxis Dr. Grafe ( Site 1005)

ER Positive, +1 more biomarker

Breast Invasive Ductal Carcinoma

cyclophosphamide, +6 more drugs

chemotherapy, +3 more types

Sacituzumab Govitecan in Primary HER2-negative Breast Cancer

~22 mi. (Nordhausen, Germany, +94 more cities)

MVZ Nordhausen gGmbH im Südharz Krankenhaus

HER2 Negative

Breast Carcinoma

sacituzumab govitecan

chemotherapy, +1 more type

A Study of Belzutifan (MK-6482) in Combination With Lenvatinib Versus Cabozantinib for Treatment of Renal Cell Carcinoma (MK-6482-011)

~35 mi. (Erfurt, Germany, +93 more cities)

Helios Klinikum Erfurt GmbH ( Site 1315)

Clear Cell Renal Cell Carcinoma

belzutifan, +1 more drug

targeted therapy

Study of Pembrolizumab With Concurrent Chemoradiation Therapy Followed by Pembrolizumab With or Without Olaparib in Stage III Non-Small Cell Lung Cancer (NSCLC) (MK-7339-012/KEYLYNK-012)

~44 mi. (Bad Berka, Germany, +158 more cities)

Zentralklinik Bad Berka GmbH ( Site 0905)

Non-Small Cell Lung Carcinoma

olaparib, +4 more drugs

chemotherapy, +3 more types

Study of Cobolimab in Combination With Dostarlimab and Docetaxel in Advanced NSCLC Participants

~44 mi. (Bad Berka, Germany, +71 more cities)

GSK Investigational Site

Non-Small Cell Lung Carcinoma

cobolimab, +2 more drugs

chemotherapy, +1 more type

Study of Pembrolizumab (MK-3475) Plus Enzalutamide Versus Placebo Plus Enzalutamide in Participants With Metastatic Castration-resistant Prostate Cancer (mCRPC) (MK-3475-641/KEYNOTE-641)

~49 mi. (Jena, Germany, +226 more cities)

Universitaetsklinikum Jena ( Site 0305)

Prostate Adenocarcinoma

enzalutamide, +1 more drug

hormone therapy, +1 more type

Efficacy and Safety of Pembrolizumab (MK-3475) in Combination With Bacillus Calmette-Guerin (BCG) in High-Risk Non-Muscle Invasive Bladder Cancer (HR NMIBC) (MK-3475-676/KEYNOTE-676)

~49 mi. (Jena, Germany, +130 more cities)

Universitaetsklinikum Jena ( Site 0252)

Bladder Urothelial Carcinoma

BCG solution, +1 more drug

immunotherapy

Placebo-controlled Study Comparing Niraparib Plus Pembrolizumab Versus Placebo Plus Pembrolizumab as Maintenance Therapy in Participants With Advanced/Metastatic Non-small Cell Lung Cancer

~49 mi. (Jena, Germany, +151 more cities)

GSK Investigational Site

Non-Small Cell Lung Carcinoma

niraparib, +1 more drug

immunotherapy, +1 more type

A Study to Evaluate Dostarlimab Plus Carboplatin-paclitaxel Versus Placebo Plus Carboplatin-paclitaxel in Participants With Recurrent or Primary Advanced Endometrial Cancer

~49 mi. (Jena, Germany, +144 more cities)

GSK Investigational Site

Endometrial Carcinoma

carboplatin, +3 more drugs

chemotherapy, +2 more types

A Study of Venetoclax and Dexamethasone Compared With Pomalidomide and Dexamethasone in Participants With Relapsed or Refractory Multiple Myeloma

~49 mi. (Jena, Germany, +156 more cities)

Universitaetsklinikum Jena /ID# 201254

IGH-CCND1 Fusion, +1 more biomarker

Multiple Myeloma

dexamethasone, +1 more drug

chemotherapy, +1 more type

KRT-232 Versus Best Available Therapy for the Treatment of Subjects With Myelofibrosis Who Are Relapsed or Refractory to JAK Inhibitor Treatment

~49 mi. (Jena, Germany, +72 more cities)

Universitätsklinikum Jena

del(11)(q10), +27 more biomarkers

Primary Myelofibrosis, +1 more condition

navtemadlin

targeted therapy

Safety and Efficacy of Lenvatinib (E7080/MK-7902) With Pembrolizumab (MK-3475) in Combination With Transarterial Chemoembolization (TACE) in Participants With Incurable/Non-metastatic Hepatocellular Carcinoma (MK-7902-012/E7080-G000-318/LEAP-012)

~52 mi. (Halle (Saale), Germany, +140 more cities)

Universitaetsklinikum Halle ( Site 0213)

Hepatocellular Carcinoma

lenvatinib, +2 more drugs

chemotherapy, +2 more types